ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA
Clinical trials for ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets Hard-to-Treat head and neck cancers
Disease control OngoingThis early-phase trial tests the safety and best dose of two drugs, vorinostat and azacitidine, given together to adults with nasopharyngeal cancer or nasal NK-T cell lymphoma that has come back or spread. The goal is to find a dose that limits side effects while potentially stop…
Matched conditions: ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:23 UTC
-
Smarter CMV strategy may protect stem cell transplant patients
Disease control OngoingThis study tested a modified approach to prevent and treat cytomegalovirus (CMV) infection in 153 people with blood cancers who had a donor stem cell transplant. The goal was to see if delaying or adjusting anti-CMV therapy could still keep patients safe while reducing unnecessar…
Matched conditions: ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 09:00 UTC